NEUTRISCI INTERNATIONAL INC. UPDATE ON CONTRACT PARTNER, NEW MARKETS AND PRODUCT LINE

Vancouver, British Columbia – August 31, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) an innovative technology company developing products for the [...]

NEUTRISCI INTERNATIONAL INC. INITIAL ORDER SEES NEUTRISCI ENTER PROMISING JAPANESE CBD MARKET

NeutriSci International Inc. (“NeutriSci” or the “Company”) is very pleased to announce that it has entered the Japanese CBD market with a strategic private label [...]

NEUTRISCI AND CRYOPHARM’S PRODUCTS DRAW SIGNIFICANT ATTENTION FROM RETAILERS AT TRADESHOW

NeutriSci International Inc. (“NeutriSci” or the “Company”) is pleased to provide a further update on its previously announced partnership with Calyx Brands [...]

NEUTRISCI FILES PATENT APPLICATION

Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT

Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]

NEUTRISCI ANNOUNCES A MAJOR R&D MOU WITH SCIENTUS PHARMA TO DEVELOP A MEDICAL CANNABINOID RETAIL PRODUCT

Vancouver, British Columbia – January 8, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and [...]

NEUTRISCI ANNOUNCES PENDING APPROVAL FROM JAPANESE GOVERNMENT FOR DISTRIBUTION OF CBD PRODUCTS THROUGH NATURALLY SPLENDID

VANCOUVER, BC – (Marketwired – November 06, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: [...]